Ascent Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Ascent Group's ELV Position: Q2 2026 in Review
Ascent Group increased its Elevance Health (ELV) stake by 25% in Q2 2026, buying an estimated $135K and bringing the position to 1,843 shares worth $713K. The position accounts for 0.02% of the portfolio, ranked #460.
Ascent Group first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.2M in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Ascent Group held 1,843 shares of Elevance Health worth $713K as of Q2 2026.
- Ascent Group bought 365 Elevance Health shares in Q2 2026, an estimated $135K.
- Elevance Health made up 0.02% of Ascent Group's portfolio in Q2 2026, its #460 holding.
- Ascent Group first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
- Ascent Group's Elevance Health position peaked at $3.2M in Q3 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.